Indo to bump up production of human H5N1 vaccines

Bio Farma Make Bird Flu Vaccine to 5 years
Thursday, December 13, 2012,
JAKARTA - PT Bio Farma to accelerate the development of vaccines penilitan and H5N1 (bird flu vaccine) within five years of which should have been 15 years old. "We can accelerate the research and development, 15 years of which should be ready in just five years" said Production Director Bio Farma, Mahendra Suhardono.

At present Bio Farma ability to produce H5N1 vaccine for humans ranges from 5000 to 10,000 doses per year. This figure is still far from expectations that prompted the World Health Organization (WHO). Each country should at least provide H5N1 vaccine to 10 percent of its population. This means that Indonesia needs about 24 million doses of vaccine to control the spread of the bird flu virus. "The vaccine, made ​​by any manufacturer should be produced in a large scale, because the vaccine is made for everyone's health," said Dr. Akira Homma.

Developing countries vaccine manufacturers, India, Vietnam, Thailand, and Brazil, have mncapai progress in the clinical trial stage. Even the production of influenza vaccines has got perkualifikasi WHO India. According to Erin Sparrow, Technology Transfer Initiatives Project Officer, Information, Evidence and Research Who, how to prevent a pandemic is to make a vaccine to prevent the threat of the spread of H5N1 virus

  http://www.republika.co.id/berita/nasional/bio-farma/12/12/13/meyayh-bio-farma-buat-vaksin-flu-burung-jadi-5-tahun?utm_source=twitterfeed&utm_medium=twitter